Beyond Air, Inc.

XAIR

Beyond Air, Inc.

XAIR

Insider Sentiment (TTM):

Last Purchase:2025-07-21Last Sale:2023-12-28Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,380,219Shares Outstanding:8,300,916Institutional Ownership Pct.:16.63%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	6	7	7	10	5	5	5	28	4	11	8	13
Marketable Securities Current	4	5	5	1	1	2	6	-	17	23	23	25
Restricted Cash Current	5	6	6	0	0	0	0	0	0	0	0	5
Accounts Receivable Net Current	1	1	1	1	1	1	1	1	0	0	0	0
Inventory Net	1	1	2	2	2	2	2	3	2	2	2	2
Prepaid Expense And Other Assets Current	5	5	5	5	5	6	5	6	6	7	6	1
Assets Current	23	25	26	19	15	16	19	38	31	44	39	47
Finite Lived Intangible Assets Net	-	-	-	-	-	-	-	-	-	-	1	2
Finite Lived License Agreements Gross	1	1	1	1	1	1	1	1	1	1	-	-
Operating Lease Right Of Use Asset	1	1	1	2	2	2	2	2	2	2	2	2
Property Plant And Equipment Net	8	8	9	9	10	11	12	12	12	9	9	7
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	33	35	37	31	28	30	34	53	47	57	52	58
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	2	2	2	1	2	2	1	3	2	3	3
Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	-	8	8
Accrued Liabilities And Other Liabilities	4	3	2	2	3	2	3	4	8	8	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Loans Payable Current	0	0	-	-	0	1	0	0	1	1	0	0
Liabilities Current	7	7	5	4	5	5	5	7	12	12	12	12
Operating Lease Liability Noncurrent	1	1	1	1	1	1	2	2	2	2	2	2
Long Term Loans Payable	22	22	22	10	10	9	-	11	15	15	14	14
Other Liabilities Noncurrent	-	-	-	2	2	-	-	-	-	-	-	-
Derivative Liabilities Noncurrent	-	-	0	-	-	-	-	-	0	1	0	0
Liabilities	30	29	28	18	18	16	16	24	29	30	28	29
Stockholders Equity
Common Stock Value	-	0	0	0	-	0	0	0	0	0	0	0
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Additional Paid In Capital	329	326	317	315	304	300	296	293	268	265	247	235
Retained Earnings Accumulated Deficit	-328	-320	-309	-302	-294	-286	-278	-265	-252	-240	-226	-210
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	-0	-0	0	0	-0	0	0
Stockholders Equity	3	6	8	13	10	14	18	29	18	27	21	29
Minority Interest	1	0	0	0	0	1	1	1	2	2	3	3
Liabilities And Stockholders Equity	33	35	37	31	28	30	34	53	47	57	52	58
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	500	500	500	500	500	500	100	100	100	500	100	100
Common Stock Shares Issued	1	1	0	0	0	0	4	4	2	2	2	2
Shares Outstanding	1	1	0	0	0	0	4	4	2	2	2	2

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-	-	-	-	-	-	-	-	-	-	-	-
2026	-30.06%	-23.10%	-34.81%	-33.91%	-54.66%	-31.61%	-22.95%	-32.38%	-51.05%	-43.64%	-	-
2025	-12.48%	-27.92%	-20.40%	-1.21%	-27.13%	-22.47%	-39.50%	-44.75%	-53.65%	-25.43%	-35.34%	-52.37%
2024	-	-	-	-27.83%	-13.30%	-14.78%	-18.14%	-23.72%	-39.53%	-57.61%	-64.70%	-68.73%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.31	3.80	5.12	4.24	3.24	3.20	3.56	5.76	2.63	3.80	3.39	3.78
Quick Ratio	2.37	2.82	3.81	2.68	1.61	1.57	2.18	4.43	1.88	3.03	2.73	3.54
Working Capital	15.94M	18.26M	20.58M	14.20M	10.36M	11.02M	13.91M	31.44M	19.12M	32.37M	27.80M	34.68M
Leverage & Debt
Debt to Equity	10.59	4.70	3.44	1.40	1.78	1.10	0.86	0.81	1.63	1.10	1.37	1.01
Interest Coverage TTM	-6.29	-8.26	-10.18	-14.43	-14.82	-14.75	-14.88	-15.01	-16.33	-21.64	-30.60	-49.93
Debt Ratio	0.91	0.82	0.77	0.58	0.63	0.52	0.46	0.45	0.62	0.52	0.55	0.50
Efficiency & Turnover
Asset Turnover TTM	0.25	0.23	0.20	0.14	0.13	0.09	0.07	0.04	0.03	0.02	0.01	0.00
Days Sales Outstanding TTM	46.15	42.68	47.18	45.55	48.81	50.69	56.33	59.30	53.12	116.37	171.90	269.46
Receivables Turnover TTM	7.91	8.55	7.74	8.01	7.48	7.20	6.48	6.16	6.87	3.14	2.12	1.35
Per Share Metrics
Diluted EPS TTM	-47.94	-82.72	-69.96	-112.77	-164.55	-275.45	-251.33	-494.30	-542.87	-38.78	-42.43	-41.13
Free Cash Flow Per Share TTM	-27.45	-46.78	-85.71	-100.83	-143.65	-260.54	-112.51	-382.07	-493.79	-37.25	-36.70	-33.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	4.18%	3.28%	1.82%	-6.70%	-24.57%	-44.89%	-70.96%	-97.61%	-78.24%	-112.77%	-159.80%	-272.82%
Operating Profit Margin TTM	-364.76%	-378.23%	-419.50%	-575.70%	-806.65%	-1,202.08%	-1,653.92%	-2,391.50%	-3,404.99%	-5,436.24%	-9,341.22%	-20,606.71%
Net Profit Margin TTM	-449.82%	-447.12%	-435.30%	-617.77%	-862.84%	-1,258.43%	-1,830.63%	-2,486.21%	-3,493.83%	-5,547.45%	-9,995.36%	-21,944.63%
Growth Metrics
Net Revenue Growth (1Y)	60.75%	107.26%	129.04%	147.74%	168.20%	219.67%	338.75%	685.91%	2,922.03%	-	-	-
Net Income Growth (1Y)	-16.20%	-26.36%	-45.54%	-38.44%	-33.77%	-27.48%	-19.64%	-10.96%	3.93%	15.19%	23.75%	29.13%
EPS Growth (1Y)	-70.87%	-69.97%	-72.17%	-77.19%	-69.69%	610.33%	492.36%	1,101.85%	1,321.22%	4.12%	14.06%	21.41%
Valuation Metrics
P/E TTM	-0.19	-0.17	-0.21	-0.41	-0.42	-0.40	-0.57	-0.31	-0.40	-17.95	-18.48	-22.47
P/B TTM	2.27	0.92	0.75	1.15	1.74	1.29	1.72	0.62	1.39	42.45	61.14	50.96
P/S TTM	0.84	0.75	0.90	2.53	3.61	4.99	10.46	7.81	13.82	995.66	1,846.92	4,930.14
Market Cap	6.43M	5.73M	6.26M	14.68M	17.25M	18.48M	31.62M	18.28M	24.65M	1.15B	1.27B	1.47B
Enterprise Value	1.16M	-611.37K	-387.16K	4.98M	12.51M	14.43M	27.08M	-9.91M	21.02M	1.14B	1.26B	1.46B
Calculated Values
Free Cash Flow TTM	-19.80M	-19.42M	-36.93M	-32.05M	-36.02M	-44.10M	-24.77M	-45.01M	-56.66M	-61.76M	-59.57M	-53.56M
Net Debt	-5.28M	-6.34M	-6.64M	-9.70M	-4.74M	-4.06M	-4.54M	-28.19M	-3.63M	-10.58M	-7.84M	-12.90M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-07-21Purchase

Owner: Lisi, Steven A.

Title: CEO and Chairman of the Board

Shares: 6,000

Price/Share: $3.25

Value: $19,500.00

Shares Owned: 3,327,411

Relationship: Director,Officer

Ownership: Direct

2025-03-14Purchase

Owner: Carey, Robert

Title: -

Shares: 1,000,000

Price/Share: $0.26

Value: $260,000.00

Shares Owned: 4,076,864

Relationship: Director

Ownership: Direct

2025-02-19Purchase

Owner: Gaul, Michael A.

Title: Chief Operating Officer

Shares: 6,000

Price/Share: $0.38

Value: $2,280.00

Shares Owned: 94,150

Relationship: Officer

Ownership: Direct

2024-09-26Purchase

Owner: Carey, Robert

Title: -

Shares: 1,476,626

Price/Share: $0.50

Value: $738,313.00

Shares Owned: 1,476,626

Relationship: Director

Ownership: Indirect

2024-09-26Purchase

Owner: Lisi, Steven A.

Title: CEO and Chairman of the Board

Shares: 1,476,626

Price/Share: $0.50

Value: $738,313.00

Shares Owned: 3,249,411

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-07-21	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	6,000	3.25	$19,500.00	3,327,411	4
2025-03-14	Carey, Robert	Director	-	Direct	Purchase	1,000,000	0.26	$260,000.00	4,076,864	4
2025-02-19	Gaul, Michael A.	Officer	Chief Operating Officer	Direct	Purchase	6,000	0.38	$2,280.00	94,150	4
2024-09-26	Carey, Robert	Director	-	Indirect	Purchase	1,476,626	0.50	$738,313.00	1,476,626	4
2024-09-26	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	1,476,626	0.50	$738,313.00	3,249,411	4
2024-08-15	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	50,000	0.37	$18,500.00	1,772,785	4
2024-08-14	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	100,000	0.39	$39,000.00	1,722,785	4
2024-08-14	Lucera, Erick	Director	-	Direct	Purchase	39,266	0.40	$15,706.40	43,608	4
2024-08-14	Carey, Robert	Director	-	Direct	Purchase	100,000	0.40	$40,000.00	3,076,864	4
2023-12-28	Avniel, Amir	Director,Officer	Chief Business Officer	Direct	Sale	11,267	2.06	$23,210.02	685,760	4
2023-12-27	Myers, Jeff Lynn	Officer	Chief Medical Officer	Direct	Sale	3,423	2.21	$7,564.83	46,577	4
2023-12-18	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	77,775	1.63	$126,773.25	1,536,471	4
2023-12-18	Carey, Robert	Director	-	Direct	Purchase	1,200,000	1.64	$1,968,000.00	2,374,454	4
2023-11-16	Gaul, Michael A.	Officer	Chief Operating Officer	Direct	Purchase	10,000	1.77	$17,700.00	88,150	4
2023-08-28	Carey, Robert	Director	-	Direct	Purchase	250,000	2.70	$675,000.00	1,225,160	4
2023-08-21	Carey, Robert	Director	-	Direct	Purchase	75,050	2.76	$207,138.00	975,160	4
2023-06-30	Gaul, Michael A.	Officer	Chief Operating Officer	Direct	Purchase	5,000	4.51	$22,550.00	78,150	4
2023-03-31	Forbes, William P	Director	-	Direct	Purchase	5,000	6.67	$33,350.00	14,855	4
2023-03-30	Carey, Robert	Director	-	Direct	Purchase	10,000	6.45	$64,500.00	886,496	4
2023-03-28	Lee, Yoori	Director	-	Direct	Purchase	3,115	6.34	$19,749.10	12,654	4
2023-03-24	Gaul, Michael A.	Officer	Chief Operating Officer	Direct	Purchase	1,000	6.15	$6,150.00	73,150	4
2023-03-20	Bentsur, Ron	Director	-	Direct	Purchase	2,300	6.48	$14,904.00	144,736	4
2023-03-17	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	10,000	6.46	$64,600.00	1,458,696	4
2023-03-17	Forbes, William P	Director	-	Direct	Purchase	5,000	6.46	$32,300.00	9,855	4
2023-03-16	Lucera, Erick	Director	-	Direct	Purchase	2,000	6.82	$13,640.00	4,342	4
2023-03-14	Carey, Robert	Director	-	Direct	Purchase	10,000	6.85	$68,500.00	866,496	4
2023-03-13	Avniel, Amir	Director,Officer	Chief Business Officer	Direct	Purchase	1,000	6.40	$6,400.00	457,027	4
2023-03-08	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Purchase	5,000	5.89	$29,450.00	1,447,849	4
2023-03-08	Carey, Robert	Director	-	Direct	Purchase	10,000	5.95	$59,500.00	852,323	4
2023-03-07	Gaul, Michael A.	Officer	Chief Operating Officer	Direct	Purchase	8,000	5.86	$46,880.00	72,150	4
2023-02-16	Lisi, Steven A.	Director,Officer	CEO and Chairman of the Board	Direct	Sale	48,596	6.10	$296,435.60	1,397,849	4
2022-12-07	Carey, Robert	Director	-	Direct	Purchase	20,000	5.75	$115,000.00	842,323	4
2022-11-29	Carey, Robert	Director	-	Direct	Purchase	15,000	5.75	$86,250.00	822,323	4
2022-11-18	Carey, Robert	Director	-	Direct	Purchase	20,000	5.80	$116,000.00	792,323	4
2022-08-22	Gaul, Michael A.	Officer	Chief Operating Officer	Direct	Purchase	2,000	9.42	$18,840.00	64,150	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

16.63%

Inst. Shares: 1,380,219

Shares Outstanding: 8,300,916

2025-12-31

16.28%

Inst. Shares: 1,402,646

Shares Outstanding: 8,616,860

2025-09-30

26.75%

Inst. Shares: 1,700,122

Shares Outstanding: 6,356,573

2025-06-30

223.85%

Inst. Shares: 11,225,745

Shares Outstanding: 5,014,923

2025-03-31

Inst. Shares: 19,170,403

Shares Outstanding: 3,385,327

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,380,219	8,300,916	16.63%
2025-12-31	1,402,646	8,616,860	16.28%
2025-09-30	1,700,122	6,356,573	26.75%
2025-06-30	11,225,745	5,014,923	223.85%
2025-03-31	19,170,403	3,385,327	-
2024-12-31	20,348,573	4,403,726	-
2024-09-30	14,973,827	2,355,927	-
2024-06-30	12,028,240	2,295,042	-
2024-03-31	16,718,973	1,658,009	-
2023-12-31	9,272,117	1,623,124	-
2023-09-30	9,229,677	1,590,025	-
2023-06-30	9,538,518	1,569,149	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Beyond Air, Inc. (XAIR) — SEC Financial Statements & Analysis

Beyond Air, Inc. (XAIR) is a surgical & medical instruments & apparatus company, incorporated in DE. Beyond Air, Inc. trades on Nasdaq as: XAIR. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Beyond Air, Inc. reported a 60.75% year-over-year revenue growth, a Gross Profit Margin of 4.18% (TTM), a Debt-to-Equity ratio of 10.59x, a Price-to-Sales (P/S) ratio of 0.84x (TTM), a Price-to-Book (P/B) ratio of 2.27x (TTM), at a market cap of $6.43M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 60.75%
Gross Profit Margin TTM: 4.18%
Debt To Equity: 10.59x
P/S TTM: 0.84x
P/B TTM: 2.27x
Market Cap: $6.43M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Beyond Air, Inc. in?

Beyond Air, Inc. (XAIR) operates in the Surgical & Medical Instruments & Apparatus industry.

What is XAIR's market cap?

Beyond Air, Inc. (XAIR) has a market capitalization of $6.43M as of 2026-06-30.

What exchange does XAIR trade on?

Beyond Air, Inc. (XAIR) trades on the Nasdaq.

Where is Beyond Air, Inc. incorporated?

Beyond Air, Inc. is incorporated in DE.

Beyond Air, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Beyond Air, Inc. (XAIR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

Beyond Air, Inc. (XAIR) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.